rs1052030
A SNP in the MYO7A gene on chromosome 11. Its most notable genotype is A;T: Carrier of a mutation for deafness
- Gene
- MYO7A
- Location
- Chr 1177,142,737 (GRCh38)
- Highest magnitude
- 3.0Important
- Tested on
- 23andMe, AncestryDNA
- Minor allele frequency
- 49%
Genotypes
As shown in 23andMe and AncestryDNA files.
On SNPedia: (A;T), (T;T). Magnitude rates how notable a genotype is from 0 to 10, not how risky it is.
Frequency
Share of each genotype in 10 HapMap populations.
- AverageA;T 0% T;T 24%
- European ancestry (Utah)A;T 0% T;T 54%
- Han Chinese (Beijing)A;T 0% T;T 30%
- Japanese (Tokyo)A;T 0% T;T 22%
- Yoruba (Nigeria)A;T 0% T;T 2%
- African ancestry (Southwest US)A;T 0% T;T 4%
- Chinese (Denver)A;T 0% T;T 21%
- Gujarati IndianA;T 0% T;T 28%
- Luhya (Kenya)A;T 0% T;T 2%
- Mexican ancestry (Los Angeles)A;T 0% T;T 44%
- TuscanA;T 0% T;T 36%
Related
Conditions, medicines and genes
Other MYO7A SNPs
- rs111033290A;AUsher syndrome type 1 (predicted)Very important
- rs111033415A;GCarrier of an Usher syndrome type 1B mutationImportant
- rs121965085C;TCarrier of an Usher syndrome type Ib mutationImportant
- rs368341987A;GProbably a benign variantWorth knowing
- rs948962C;Ccommon in clinvarTypical
- rs139889944G;Gcommon in clinvarTypical
Notes
From SNPedia
Notes
aka c.47T>C (p.Leu16Ser) and also c.47T>A (p.Leu16Ter); the former is benign, while the latter is pathogenic for a recessive form of deafness (type 2, Usher syndrome) Susceptibility genes for gentamicin-induced vestibular dysfunction.
A;T
Unaffected in absence of a second mutation in the MYO7A gene; see links via main rs-page
Source and license
Adapted from rs1052030 on SNPedia, using a snapshot taken October 16, 2026. SNPedia content is shared under CC BY-NC-SA 3.0 US, and this page is shared under the same license.
SNPedia is a community-edited wiki. Its entries can be incomplete, out of date or wrong, and nothing here is a diagnosis or medical advice. Magnitude is a community rating of how interesting a genotype is, not a risk score.